BioCryst board chair Nancy Hutson to retire; Vincent Milano named successor

BIOCRYST PHARMACEUTICALS INC

Nancy J. Hutson notified retirement from BioCryst board, effective earlier of Astria acquisition close or 2026 annual meeting.
Hutson to continue as Chair and committee member until Retirement Date; cited no disagreement with board or management.
Vincent J. Milano elected as next Board Chair, effective on Hutson's Retirement Date.
Hutson served 14 years on the BioCryst board.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.